David Loasby
- SEC CIK
- 0001775863
- Latest filing
- Feb 13, 2026
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by David Loasby, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q4 2025 holdings
- Shares (Q4 2025)
- 711
- Value
- $327.5K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 711 | $327.5K | <0.1% | −124−14.9% | Reduced | Holders |
| Q3 2025 | 835 | $342.6K | <0.1% | −250−23.0% | Reduced | Holders |
| Q2 2025 | 1,085 | $501.4K | <0.1% | +148+15.8% | Added | Holders |
| Q1 2025 | 937 | $445.5K | <0.1% | +234+33.3% | Added | Holders |
| Q4 2024 | 703 | $287.9K | <0.1% | +62+9.7% | Added | Holders |
| Q3 2024 | 641 | $290.7K | <0.1% | +28+4.6% | Added | Holders |
| Q2 2024 | 613 | $301.4K | <0.1% | +67+12.3% | Added | Holders |
| Q1 2024 | 546 | $220.8K | <0.1% | −51−8.5% | Reduced | Holders |
| Q4 2023 | 597 | $248.7K | <0.1% | +25+4.4% | Added | Holders |
| Q3 2023 | 572 | $201.9K | <0.1% | +572 | New | Holders |